More Peptides 5-Amino-1MQ (10mg) BPC-157 BPC-157, TB-500, GHK-Cu (Glow Blend) 60mg CJC-1295 (no DAC), Ipamorelin 10mg (Blend) GHK-Cu 50mg Copper Peptide Kisspeptin-10 5mg KPV (Ac-KPV-NH2) 5mg MOTS-c NAD+ Retatrutide peptide Selank 10mg Semax TB-500 (Thymosin Beta-4) (43aa) Tesamorelin 5mg Thymosin Alpha-1 Tirzepatide peptide Properties Molecular Formula Bpc-157: CHNO Cu-GHK: CHCuNO Timbetasin: CHNO Molecular Weight Bpc-157: 1419.5 Cu-GHK: 403.92 Timbetasin: 4963 Monoisotopic Mass Bpc-157: 1418.70415882 Cu-GHK: 403.1155 Timbetasin: 4960.4863169 Polar Area Bpc-157: 573 Cu-GHK: 176 Timbetasin: 2250 Complexity Bpc-157: 3040 Cu-GHK: 6 Timbetasin: 12200 XLogP Bpc-157: -9 Timbetasin: -43.5 Heavy Atom Count Bpc-157: 100 Cu-GHK: 25 Timbetasin: 347 Hydrogen Bond Donor Count Bpc-157: 16 Cu-GHK: 6 Timbetasin: 72 Rotatable Bond Count Bpc-157: 39 Cu-GHK: 11 Timbetasin: 180 Hydrogen Bond Acceptor Count Bpc-157: 24 Cu-GHK: 7 Timbetasin: 88 Identifiers CID Bpc-157: 9941957 Cu-GHK: 378611 Timbetasin: 16132341 InChI Bpc-157: InChI=1S/C62H98N16O22/c1-31(2)25-37(55(92)74-50(32(3)4)62(99)100)71-46(81)29-65-51(88)33(5)67-53(90)38(26-48(84)85)73-54(91)39(27-49(86)87)72-52(89)34(6)68-57(94)41-15-10-21-75(41)58(95)35(13-7-8-20-63)70-45(80)30-66-56(93)40-14-9-22-76(40)60(97)43-17-12-24-78(43)61(98)42-16-11-23-77(42)59(96)36(18-19-47(82)83)69-44(79)28-64/h31-43,50H,7-30,63-64H2,1-6H3,(H,65,88)(H,66,93)(H,67,90)(H,68,94)(H,69,79)(H,70,80)(H,71,81)(H,72,89)(H,73,91)(H,74,92)(H,82,83)(H,84,85)(H,86,87)(H,99,100)/t33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,50-/m0/s1 Cu-GHK: InChI=1S/C14H24N6O4.Cu/c15-4-2-1-3-10(14(23)24)20-13(22)11(19-12(21)6-16)5-9-7-17-8-18-9;/h7-8,10-11H,1-6,15-16H2,(H,17,18)(H,19,21)(H,20,22)(H,23,24)
Purpose: This test is essential for diagnosing vitamin B12 deficiency, monitoring treatment effectiveness, and understanding the underlying causes of related health conditions
Anyone telling you its a proven human fat-loss treatment is stretching past what the evidence supports
The peptide's actin-binding properties enable precise control of cytoskeletal dynamics in cell culture systems, measurable through fluorescent phalloidin staining and live-cell imaging approaches
Patient Success Factors Our most successful patients combine AOD 9604 with: Structured nutrition protocols Regular cardiovascular exercise Adequate sleep (7-9 hours nightly) Stress management practices Consistent monitoring and adjustments Clinical Trial Data and Research Landmark Australian Study The pivotal clinical trial conducted by Metabolic Pharmaceuticals tested six different doses in 300 obese patients over 12 weeks
